IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Peer Comparison
Performance
Performance Report
Glenmark Life Sciences IPO listing price is ₹ 748.20, issue price is ₹ 720.00, and currently trading at ₹ 936.40 as on August 7, 2025. Glenmark Life Sciences IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Glenmark Life Sciences IPO is a Book Building listing on BSE,NSE exchange. The company is based in Solapur and caters to Pharmaceutical sector. Bob Capital Markets , Bofa Securities India , Dam Capital Advisors (Formerly Idfc Securities ) , Goldman Sachs (India) Securities are the merchant bankers of Glenmark Life Sciences IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 16th April 2021.
Glenmark Life Sciences IPO offer price is ₹ 720.00 and got listed at ₹ 748.20. Read Glenmark Life Sciences IPO details mentioned above.The IPO of Glenmark Life Sciences Limited was listed on 6th August 2021. As of today, Glenmark Life Sciences IPO is trading at ₹ 936.40, compared to the previous day’s close of ₹ 950.80. Read the report above for detailed IPO performance.
The issue price of Glenmark Life Sciences IPO was ₹ 720.00 per equity share.
Glenmark Life Sciences IPO was listed at ₹748.20 on the stock exchange on 6th August 2021. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of August 7, 2025, the current market price of Glenmark Life Sciences IPO is ₹ 936.40.
The 52-week high for Glenmark Life Sciences IPO is [●], while the 52-week low is [●]. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Glenmark Life Sciences IPO listed at ₹ 748.20 against the issue price of ₹ 720.00 per equity share, showing a listing day gain/loss of 28.2 (3.92%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Glenmark Life Sciences IPO stock moved from its listing price of ₹ 748.20 to the current price of ₹936.40 per equity share, reflecting a change of 25.15% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Glenmark Life Sciences IPO issue date of 6th August 2021 and CMP of ₹936.40, the estimated CAGR is approximately 6.78%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 2
Issue
Price :
₹ 720.00
Listing Price :
₹ 748.20
Previous Day Closing
₹ 950.80
Glenmark Life Sciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Glenmark Life Sciences Financial Review Page
Merchant Banker(s) of Glenmark Life Sciences IPO: Bob Capital Markets Limited , Bofa Securities India Limited , Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Goldman Sachs (India) Securities Private Limited
Glenmark Life Sciences IPO subscription was 44.17 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Glenmark Life Sciences IPO listed at a listing price of 748.20 against the offer price of 720.00.
The current market price of Glenmark Life Sciences is 936.40.
Why Us?
